Travere Therapeutics TVTX
NASDAQ TVTX
$52.04 +0.05 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

Travere Therapeutics (TVTX) Return on Assets [ROA] (2010 - 2026)

Updated

Travere Therapeutics' Return on Assets [ROA] was -14.75% in Q3 2026, up 1.44 percentage points from -16.19% a year earlier but down 8.33 percentage points from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Return on Assets [ROA] (2010 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Travere Therapeutics came in at -4.26%, up 42.24 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of +23.69 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -46.50% in FY2024 (-31.25 pp), -15.24% in FY2023 (+23.19 pp), -38.43% in FY2022 (-12.41 pp) and -26.02% in FY2021 (+1.93 pp).
  • Quarterly Return on Assets [ROA] has moved between -66.60% (Q3 2024) and -3.69% (Q1 2026) over five years.
  • Compared with a year earlier, Return on Assets [ROA] has increased for five straight quarters, with an average year-over-year change of +12.15 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2025 (a gain of 54.08 percentage points); the worst was Q3 2024 (a drop of 55.51 percentage points).
  • Per Business Quant data, TVTX's Return on Assets [ROA] in the three quarters before Q3 2026 was -6.42% (Q2 2026), -3.69% (Q1 2026) and -4.47% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Travere Therapeutics 4.97 Bn 4.56 Bn 221.70 Mn -14.87%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -14.87%
Jun 30, 2026 -6.46%
Mar 31, 2026 -3.73%
Dec 31, 2025 -4.66%
Sep 30, 2025 -16.19%
Jun 30, 2025 -30.47%
Mar 31, 2025 -39.49%
Dec 31, 2024 -58.29%
Sep 30, 2024 -66.09%
Jun 30, 2024 -23.66%
Mar 31, 2024 -22.15%
Dec 31, 2023 -13.56%
Sep 30, 2023 -11.60%
Jun 30, 2023 -40.17%
Mar 31, 2023 -39.08%
Dec 31, 2022 -40.15%
Sep 30, 2022 -34.99%
Jun 30, 2022 -28.69%
Mar 31, 2022 -25.37%
Dec 31, 2021 -23.17%
API Access

Travere Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=TVTX&period=max&api_key=YOUR_API_KEY